A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics-Reference-Cited by-同舟云学术

A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristics

Published:2005-10 Issue:6 Volume:7 Page:1059-1069
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Kjekshus John¹,Dunselman Peter²,Blideskog Malin³,Eskilson Christina³,Hjalmarson Åke⁴,McMurray John V.⁵,Waagstein Finn⁴,Wedel Hans⁶,Wessman Peter³,Wikstrand John³⁴,

Affiliation:

1. Department of Cardiology, Rikshospitalet University Hospital; University of Oslo; Sognsvannsveien 20 Oslo 0027 Norway

2. Department of Cardiology; Ampia Hospital; Breda The Netherlands

3. AstraZeneca R&D; Mölndal Sweden

4. Wallenberg Laboratory for Cardiovascular Research; Sahlgrenska University Hospital; Göteborg Sweden

5. Department of Cardiology; Western Infirmary; Glasgow UK

6. Nordic School of Public Health; Göteborg Sweden

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Scandinavian Simvastatin Survival Study Group;Lancet,1994

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N Engl J Med,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N Engl J Med,1996

4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels;The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group;N Engl J Med,1998

5. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study;Downs;JAMA,1998

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?;Current Atherosclerosis Reports;2023-12

2. Statins in Primary Prevention in People Over 80 Years;The American Journal of Cardiology;2023-01

3. Hydrophilic or Lipophilic Statins?;Frontiers in Cardiovascular Medicine;2021-05-20

4. Effect of atorvastatin on the lipid profile, markers of immune inflammation and symptomatic severity of heart failure in patients with myocarditis;Bulletin of the Russian Military Medical Academy;2020-12-15

5. 2020 Clinical practice guidelines for Chronic heart failure;Russian Journal of Cardiology;2020-12-05